St Luke's Hospital, Chesterfield, MI Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2006
NCT00380003
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2006

Timeline

NOW
  • Now

Alternative names

St Luke's Hospital, Sleep Medicine and Research Center, Chesterfield, MI | St. Luke's Hospital, Sleep Medicine and Research Center, Chesterfield, MI

Active Ingredients

Drugs in Phase 2 Trials (1)

evt 201 (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Sleepiness (Phase 2)

Sleep Initiation and Maintenance Disorders (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 1